1.12
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | MBRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 1.12 | 0.00 | 0.00 | 0.00 | 1.12 | 05:34:59 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.13 | 1.14 | 0.01 | 0.88% | - | - |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 3 | 143 | 5,832,694 | 0.323 - 1.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 05:34:58 | 39 | $ 1.12 | USD |
Moleculin Biotech Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 67.65M | 60.40M | 53.49M | $ - | $ - | -0.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Moleculin Biotech News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.09 | 1.16 | 1.00 | 1.14 | 1,218,417 | 0.03 | 2.75% |
| 1 Month | 0.88 | 1.74 | 0.78 | 1.14 | 8,169,467 | 0.24 | 27.27% |
| 3 Months | 1.02 | 1.74 | 0.78 | 1.13 | 4,201,137 | 0.10 | 9.8% |
| 6 Months | 0.878 | 1.97 | 0.323 | 1.13 | 5,172,962 | 0.242 | 27.56% |
| 1 Year | 1.10 | 1.97 | 0.323 | 1.12 | 2,604,661 | 0.02 | 1.82% |
| 3 Years | 2.88 | 3.34 | 0.323 | 1.47 | 1,416,763 | -1.76 | -61.11% |
| 5 Years | 8.99 | 9.58 | 0.323 | 1.60 | 1,269,386 | -7.87 | -87.54% |
Moleculin Biotech Description
| Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis. |
